Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880603 · ClinicalTrials.gov registry record · Phase 2
Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site
A Phase 2 study, sponsored by Nebraska Methodist Health System.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT04880603: Clinical Trial Phase 2 study, sponsored by Nebraska Methodist Health System.
NCT04880603 is a Phase 2 study that was terminated before completion, run by Nebraska Methodist Health System. The registered enrollment target is 5 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04880603, a Phase 2 study, was terminated before completion, sponsored by Nebraska Methodist Health System.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
Adult patients undergoing a radial forearm free flap or ulnar forearm free flap will be randomized to the use of the Restrata graft in combination with split-thickness skin graft for reconstruction. Photos will document whether the Restata graft aids in the healing.
Primary Outcome
Tendon exposure at four weeks post-operatively (Yes/No).
Interventions
- DEVICE Restrata Graft
- PROCEDURE Standard of Care Skin Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-04-05 |
| Est. Completion | 2022-04-25 |
| Phase | Phase 2 |
Why NCT04880603 stopped before completion
NCT04880603 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Restrata Graft is the first listed.
NCT04880603 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04880603 about?
NCT04880603 is a clinical study titled "Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site". Adult patients undergoing a radial forearm free flap or ulnar forearm free flap will be randomized to the use of the Restrata graft in combination with split-thickness skin graft for reconstruction. Photos will document whether the Restata graft aids in the healing.
What is the current status of trial NCT04880603?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2021-04-05. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT04880603?
The interventions under investigation include: Restrata Graft (DEVICE), Standard of Care Skin Graft (PROCEDURE).
Who is sponsoring clinical trial NCT04880603?
This trial is sponsored by Nebraska Methodist Health System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04880603's enrollment target sits among peer trials
5 2000th of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI